Cas12a/Guide RNA-Based Platform for Rapidly and Accurately Detecting bla_KPC Gene in Carbapenem-Resistant Enterobacterales

References

• Tamma PD, Aitken SL, Bonomo RA, et al. Infectious diseases society of America guidance on the treatment of AmpC β-lactamase-producing enterobacterales, carbapenem-resistant Acinetobacter baumannii, and stenotrophomonas maltophilia infections. Clin Infect Dis. 2022;74(12):2089–2114. doi:10.1093/cid/ciab1013
   PubMed Web of Science ®Google Scholar
• Serral F, Castello FA, Sosa EJ, et al. From Genome to Drugs: New Approaches in Antimicrobial Discovery. Front Pharmacol. 2021;12:647060. doi:10.3389/fphar.2021.647060
   Web of Science ®Google Scholar
• Antimicrobial Resistance Collaborators. “Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.” Lancet (London, England). 2022;399(10325): 629–655. doi:10.1016/S0140-6736(21)02724-0
   PubMed Web of Science ®Google Scholar
• Perez F, Villegas MV. The role of surveillance systems in confronting the global crisis of antibiotic-resistant bacteria. Curr Opin Infect Dis. 2015;28(4):375–383. doi:10.1097/QCO.0000000000000182
   Web of Science ®Google Scholar
• Feil EJ. Enterobacteriaceae: joining the dots with pan-European epidemiology. Lancet Infect Dis. 2017;17(2):118–119. doi:10.1016/S1473-3099(16)30333-4
   Web of Science ®Google Scholar
• Han R, Shi Q, Wu S, et al. Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) among carbapenem-resistant Enterobacteriaceae isolated from adult and children patients in China. Front Cell Infect Microbiol. 2020;10:314. doi:10.3389/fcimb.2020.00314
   PubMed Web of Science ®Google Scholar
• Ruppé É, Woerther PL, Barbier F. Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care. 2015;5(1):61. doi:10.1186/s13613-015-0061-0
   PubMed Web of Science ®Google Scholar
• Nordmann P, Poirel L. Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria. Clin Infect Dis. 2019;69(Supplement_7):S521–s528. doi:10.1093/cid/ciz824
   PubMed Web of Science ®Google Scholar
• Kazmierczak KM, Karlowsky JA, de Jonge BLM, Stone GG, Sahm DF. Epidemiology of carbapenem resistance determinants identified in meropenem-nonsusceptible enterobacterales collected as part of a global surveillance program, 2012 to 2017. Antimicrob Agents Chemother. 2021;65(7):e0200020. doi:10.1128/AAC.02000-20
   PubMed Web of Science ®Google Scholar
• Albiger B, Glasner C, Struelens MJ, Grundmann H, Monnet DL. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Euro Surveill. 2015;3:20.
   Google Scholar
• Villegas MV, Pallares CJ, Escandón-Vargas K, et al. Characterization and clinical impact of bloodstream infection caused by carbapenemase-producing Enterobacteriaceae in seven Latin American Countries. PLoS One. 2016;11(4):e0154092. doi:10.1371/journal.pone.0154092
   PubMed Web of Science ®Google Scholar
• Iovleva A, Doi Y. Carbapenem-Resistant Enterobacteriaceae. Clin Lab Med. 2017;37(2):303–315. doi:10.1016/j.cll.2017.01.005
   PubMed Web of Science ®Google Scholar
• Nimer NA. Nosocomial Infection and antibiotic-resistant threat in the Middle East. Infect Drug Resist. 2022;15:631–639. doi:10.2147/IDR.S351755
   PubMed Web of Science ®Google Scholar
• Mouftah SF, Pál T, Darwish D, et al. Epidemic IncX3 plasmids spreading carbapenemase genes in the United Arab Emirates and worldwide. Infect Drug Resist. 2019;12:1729–1742. doi:10.2147/IDR.S210554
   PubMed Web of Science ®Google Scholar
• Stewardson AJ, Marimuthu K, Sengupta S, et al. Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study. Lancet Infect Dis. 2019;19(6):601–610. doi:10.1016/S1473-3099(18)30792-8
   PubMed Web of Science ®Google Scholar
• Ben-David D, Maor Y, Keller N, et al. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol. 2010;31(6):620–626. doi:10.1086/652528
   Web of Science ®Google Scholar
• Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol. 2008;29(12):1099–1106. doi:10.1086/592412
   PubMed Web of Science ®Google Scholar
• Satlin MJ, Calfee DP, Chen L, et al. Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies. Leuk Lymphoma. 2013;54(4):799–806. doi:10.3109/10428194.2012.723210
   PubMed Web of Science ®Google Scholar
• Davoudi-Monfared E, Khalili H. The threat of carbapenem-resistant gram-negative bacteria in a Middle East region. Infect Drug Resist. 2018;11:1831–1880. doi:10.2147/IDR.S176049
   PubMed Web of Science ®Google Scholar
• Perez S, Innes GK, Walters MS, et al. Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions - new Jersey, February–July 2020. MMWR Morb Mortal Wkly Rep. 2020;69(48):1827–1831. doi:10.15585/mmwr.mm6948e1
   PubMed Web of Science ®Google Scholar
• Bartsch SM, McKinnell JA, Mueller LE, et al. Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Clin Microbiol Infect. 2017;23(1):48.e49–48.e16. doi:10.1016/j.cmi.2016.09.003
   Web of Science ®Google Scholar
• Durante-Mangoni E, Andini R, Zampino R. Management of carbapenem-resistant Enterobacteriaceae infections. Clin Microbiol Infect. 2019;25(8):943–950. doi:10.1016/j.cmi.2019.04.013
   PubMed Web of Science ®Google Scholar
• van Duin D, Lok JJ, Earley M, et al. Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae. Clin Infect Dis. 2018;66(2):163–171. doi:10.1093/cid/cix783
   PubMed Web of Science ®Google Scholar
• Ackley R, Roshdy D, Meredith J, et al. Meropenem-vaborbactam versus ceftazidime-avibactam for treatment of carbapenem-resistant Enterobacteriaceae infections. Antimicrob Agents Chemother. 2020;64(5). doi:10.1128/AAC.02313-19
   PubMed Web of Science ®Google Scholar
• Reyes S, Nicolau DP. Precision medicine for the diagnosis and treatment of carbapenem-resistant Enterobacterales: time to think from a different perspective. Expert Rev Anti Infect Ther. 2020;18(8):721–740. doi:10.1080/14787210.2020.1760844
   PubMed Web of Science ®Google Scholar
• Chen JSM, Jennifer A, Harrington LB. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science. 2018;360(6387):436–439. doi:10.1126/science.aar6245
   PubMed Web of Science ®Google Scholar
• Broughton JP, Deng X, Yu G, et al. CRISPR-Cas12-based detection of SARS-CoV-2. Nat Biotechnol. 2020;38(7):870–874. doi:10.1038/s41587-020-0513-4
   PubMed Web of Science ®Google Scholar
• Lei R, Li L, Wu P, et al. RPA/CRISPR/Cas12a-based on-site and rapid nucleic acid detection of toxoplasma gondii in the environment. ACS Synth Biol. 2022;11(5):1772–1781. doi:10.1021/acssynbio.1c00620
   PubMed Web of Science ®Google Scholar
• Tarim EA, Oksuz C, Karakuzu B, et al. Electromechanical RT-LAMP device for portable SARS-CoV-2 detection. Talanta. 2023;254:124190. doi:10.1016/j.talanta.2022.124190
   Web of Science ®Google Scholar
• Tabatabaei MS, Islam R, Ahmed M. Applications of gold nanoparticles in ELISA, PCR, and immuno-PCR assays: a review. Anal Chim Acta. 2021;1143:250–266. doi:10.1016/j.aca.2020.08.030
   PubMed Web of Science ®Google Scholar
• Li SY, Cheng Q-X, Wang J-M, et al. CRISPR-Cas12a-assisted nucleic acid detection. Cell Discov. 2018;4(1):20. doi:10.1038/s41421-018-0028-z
   Google Scholar
• Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–1596. doi:10.1097/01.CCM.0000217961.75225.E9
   PubMed Web of Science ®Google Scholar
• Schwaber MJ, Carmeli Y. An ongoing national intervention to contain the spread of carbapenem-resistant Enterobacteriaceae. Clin Infect Dis. 2014;58(5):697–703. doi:10.1093/cid/cit795
   PubMed Web of Science ®Google Scholar
• Zhang WS, Pan J, Li F, et al. Reverse transcription recombinase polymerase amplification coupled with CRISPR-Cas12a for facile and highly sensitive colorimetric SARS-CoV-2 detection. Anal Chem. 2021;93(8):4126–4133. doi:10.1021/acs.analchem.1c00013
   Web of Science ®Google Scholar
• Choi JH, Lim J, Shin M, Paek SH, Choi JW. CRISPR-Cas12a-based nucleic acid amplification-free DNA biosensor via au nanoparticle-assisted metal-enhanced fluorescence and colorimetric analysis. Nano Lett. 2021;21(1):693–699. doi:10.1021/acs.nanolett.0c04303
   PubMed Web of Science ®Google Scholar